Essential Partners’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$80 Sell
26
-505
-95% -$1.71K ﹤0.01% 2764
2026
Q1
$2.22K Sell
531
-134
-20% -$559 ﹤0.01% 1966
2025
Q4
$2.87K Sell
665
-18
-3% -$69 ﹤0.01% 1666
2025
Q3
$2.96K Buy
+683
New +$3.08K ﹤0.01% 1642

Other funds holding SBC

Essential Partners's SBC Position: Q2 2026 in Review

Essential Partners reduced its SBC Medical Group (SBC) stake by 95% in Q2 2026, selling an estimated $1.71K and leaving 26 shares worth $80. The position accounts for ﹤0.01% of the portfolio, ranked #2764.

Essential Partners first reported a position in SBC in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.96K in Q3 2025. 57 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Essential Partners held 26 shares of SBC Medical Group worth $80 as of Q2 2026.
  • Essential Partners sold 505 SBC Medical Group shares in Q2 2026, an estimated $1.71K.
  • SBC Medical Group made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2764 holding.
  • Essential Partners first reported a position in SBC Medical Group in Q3 2025 and has held it in 4 quarters since.
  • Essential Partners's SBC Medical Group position peaked at $2.96K in Q3 2025.
  • 57 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.